BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25162664)

  • 1. The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus.
    Brancato D; Fleres M; Aiello V; Saura G; Scorsone A; Ferrara L; Provenzano F; Di Noto A; Spano L; Provenzano V
    Diabetes Technol Ther; 2014 Nov; 16(11):735-41. PubMed ID: 25162664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia.
    Hanas R; Adolfsson P
    Pediatr Diabetes; 2006 Feb; 7(1):25-31. PubMed ID: 16489971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of long-term insulin pump treatment in patients with type 1 diabetes aged over 50 years.
    Matejko B; Krzyżowska S; Kieć-Wilk B; Malecki MT; Klupa T
    Endocr J; 2020 Mar; 67(3):367-371. PubMed ID: 32023570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
    Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    Alotaibi A; Al Khalifah R; McAssey K
    Pediatr Diabetes; 2020 Nov; 21(7):1256-1267. PubMed ID: 32738022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes.
    Summers JC; Briganti EM; Fitzgerald ZA; Lambers LNJ; Cohen ND
    Diabetes Technol Ther; 2019 Aug; 21(8):423-429. PubMed ID: 31180239
    [No Abstract]   [Full Text] [Related]  

  • 13. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
    Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
    Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study.
    Scaramuzza AE; Iafusco D; Rabbone I; Bonfanti R; Lombardo F; Schiaffini R; Buono P; Toni S; Cherubini V; Zuccotti GV;
    Diabetes Technol Ther; 2011 Feb; 13(2):99-103. PubMed ID: 21284475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
    Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
    Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.
    Mameli C; Scaramuzza AE; Ho J; Cardona-Hernandez R; Suarez-Ortega L; Zuccotti GV
    Acta Diabetol; 2014 Apr; 51(2):205-10. PubMed ID: 23681558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.
    Viner RM; White B; Amin R; Peters C; Khanolkar A; Christie D; Hindmarsh PC
    Pediatr Diabetes; 2017 Aug; 18(5):384-391. PubMed ID: 27534520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.